Is It Time to Invest in Pfizer? Exploring its 7% Dividend Yield and Growth Potential

  • Pfizer (NYSEFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent COVID vaccine demand through the roof.